Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS

Multigene assays such as the 21-gene recurrence score (RS) quantify risk for recurrence and potential benefit from chemotherapy in early-stage, ER+ breast cancers. Few studies have assessed the impact of testing on patient-reported outcomes such as cancer-related distress or quality of life. The few...

Descripción completa

Detalles Bibliográficos
Autores principales: Sulayman, Nadiyah, Spellman, Elizabeth, Graves, Kristi D., Peshkin, Beth N., Isaacs, Claudine, Schwartz, Marc D., O'Neill, Suzanne C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413972/
https://www.ncbi.nlm.nih.gov/pubmed/22899924
http://dx.doi.org/10.1155/2012/728290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413972/
https://www.ncbi.nlm.nih.gov/pubmed/22899924
http://dx.doi.org/10.1155/2012/728290

Ejemplares similares